Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenue:
Total net revenues	$ 69,387	$ 66,909	$ 137,909	$ 126,242
Cost of goods sold	$ 24,067	$ 19,841	$ 45,934	$ 38,671
Cost, Product and Service [Extensible Enumeration]	Product revenue, net	Product revenue, net	Product revenue, net	Product revenue, net
Gross profit	$ 45,320	$ 47,068	$ 91,975	$ 87,571
Operating expenses:
Selling, general and administrative	56,675	50,152	113,315	95,275
Research and development	1,837	2,350	4,049	4,428
Revaluation of contingent royalty obligation payable to Evolus Founders	(3,914)	1,605	(1,763)	3,183
Depreciation and amortization	932	663	1,756	1,309
Total operating expenses	55,530	54,770	117,357	104,195
Loss from operations	(10,210)	(7,702)	(25,382)	(16,624)
Other income (expense):
Interest income	479	1,029	1,189	1,546
Interest expense	(7,207)	(4,696)	(11,622)	(9,398)
Other income (expense), net	(151)	62	(94)	107
Loss before income taxes	(17,089)	(11,307)	(35,909)	(24,369)
Income tax expense	(53)	(43)	(125)	(90)
Net loss	(17,142)	(11,350)	(36,034)	(24,459)
Other comprehensive income (loss), net of tax:
Currency translation adjustment	240	(44)	306	(174)
Comprehensive loss	$ (16,902)	$ (11,394)	$ (35,728)	$ (24,633)
Net loss per share, basic (in dollars per share)	$ (0.27)	$ (0.18)	$ (0.56)	$ (0.40)
Net loss per share, diluted (in dollars per share)	$ (0.27)	$ (0.18)	$ (0.56)	$ (0.40)
Weighted-average shares outstanding used to compute basic net loss per share (in shares)	64,539,291	62,724,604	64,120,287	60,760,958
Weighted-average shares outstanding used to compute diluted net loss per share (in shares)	64,539,291	62,724,604	64,120,287	60,760,958
Product revenue, net
Revenue:
Total net revenues	$ 68,699	$ 66,222	$ 136,773	$ 125,186
Service revenue
Revenue:
Total net revenues	$ 688	$ 687	$ 1,136	$ 1,056